These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7502518

  • 21. Carvedilol.
    Frishman WH.
    N Engl J Med; 1998 Dec 10; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract] [Full Text] [Related]

  • 22. Clinical pharmacokinetics and pharmacodynamics of carvedilol.
    Morgan T.
    Clin Pharmacokinet; 1994 May 10; 26(5):335-46. PubMed ID: 7914479
    [Abstract] [Full Text] [Related]

  • 23. Antihypertensive profile of carvedilol.
    Meyer-Sabellek W, Agrawal B.
    Clin Investig; 1992 May 10; 70 Suppl 1():S43-52. PubMed ID: 1350484
    [Abstract] [Full Text] [Related]

  • 24. The effect of carvedilol on metabolic parameters in patients with metabolic syndrome.
    Uzunlulu M, Oguz A, Yorulmaz E.
    Int Heart J; 2006 May 10; 47(3):421-30. PubMed ID: 16823248
    [Abstract] [Full Text] [Related]

  • 25. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    McTavish D, Campoli-Richards D, Sorkin EM.
    Drugs; 1993 Feb 10; 45(2):232-58. PubMed ID: 7681374
    [Abstract] [Full Text] [Related]

  • 26. Clinical experience with moxonidine.
    Prichard BN.
    Cardiovasc Drugs Ther; 1994 Mar 10; 8 Suppl 1():49-58. PubMed ID: 8068579
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S, Masumura H, Kaifu Y, Yuasa S.
    J Cardiovasc Pharmacol; 1991 Mar 10; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [Abstract] [Full Text] [Related]

  • 28. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R.
    Acta Med Scand Suppl; 1984 Mar 10; 689():1-46. PubMed ID: 6151343
    [Abstract] [Full Text] [Related]

  • 29. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U.
    J Cardiovasc Pharmacol; 1987 Mar 10; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?
    Chapman N, Chen CY, Fujita T, Hobbs FD, Kim SJ, Staessen JA, Tanomsup S, Wang JG, Williams B.
    J Hypertens; 2010 Sep 10; 28(9):1796-803. PubMed ID: 20543713
    [Abstract] [Full Text] [Related]

  • 32. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women].
    Latfullin IA, Ishmurzin GP, Gaĭfullina RF, Akhmerova RI, Kim ZF, Podol'skaia AA.
    Klin Med (Mosk); 2010 Sep 10; 88(2):68-71. PubMed ID: 21105477
    [Abstract] [Full Text] [Related]

  • 33. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul 10; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 34. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
    Si D, Wang J, Xu Y, Chen X, Zhang M, Zhou H.
    J Cardiovasc Pharmacol; 2014 Oct 10; 64(4):306-9. PubMed ID: 25291495
    [Abstract] [Full Text] [Related]

  • 35. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T, Yoshinaga K, Kamahara Y, Ikeda M, Goto Y, Arakawa K, Iimura I, Ishii M, Kokubu T, Takeda T.
    J Cardiovasc Pharmacol; 1991 Oct 10; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [Abstract] [Full Text] [Related]

  • 36. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
    McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D.
    Drugs; 1988 Oct 10; 36 Suppl 6():82-91. PubMed ID: 2908306
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms.
    Brunvand H, Kvitting PM, Rynning SE, Berge RK, Grong K.
    J Cardiovasc Pharmacol; 1996 Sep 10; 28(3):409-17. PubMed ID: 8877588
    [Abstract] [Full Text] [Related]

  • 39. [Moxonidine. A new centrally active antihypertensive drug].
    Schrader J, Molderings GJ, Dominiak P.
    Internist (Berl); 1992 Oct 10; 33(10):704-6. PubMed ID: 1428688
    [No Abstract] [Full Text] [Related]

  • 40. Moxonidine for hypertension.
    Drug Ther Bull; 1997 May 10; 35(5):33-6. PubMed ID: 9282418
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.